• Advertise
  • Contact Us
  • About Us
  • Supplier Directory
  • SCB YouTube
  • Login
  • Subscribe
  • Logout
  • My Profile

  • CORONAVIRUS
  • LOGISTICS
    • Air Cargo
    • All Logistics
    • Express/Small Shipments
    • Facility Location Planning
    • Freight Forwarding/Customs Brokerage
    • Global Gateways
    • Global Logistics
    • Last Mile Delivery
    • Logistics Outsourcing
    • LTL/Truckload Services
    • Ocean Transportation
    • Rail & Intermodal
    • Reverse Logistics
    • Service Parts Management
    • Transportation & Distribution
  • TECHNOLOGY
    • All Technology
    • Artificial Intelligence
    • Cloud & On-Demand Systems
    • Data Management (Big Data/IoT/Blockchain)
    • ERP & Enterprise Systems
    • Forecasting & Demand Planning
    • Global Trade Management
    • Inventory Planning/ Optimization
    • Product Lifecycle Management
    • Sales & Operations Planning
    • SC Finance & Revenue Management
    • SC Planning & Optimization
    • Sourcing/Procurement/SRM
    • Supply Chain Visibility
    • Transportation Management
  • GENERAL SCM
    • Business Strategy Alignment
    • Education & Professional Development
    • Global Supply Chain Management
    • Global Trade & Economics
    • HR & Labor Management
    • Quality & Metrics
    • Regulation & Compliance
    • SC Security & Risk Mgmt
    • Supply Chains in Crisis
    • Sustainability & Corporate Social Responsibility
  • WAREHOUSING
    • All Warehouse Services
    • Conveyors & Sortation
    • Lift Trucks & AGVs
    • Order Fulfillment
    • Packaging
    • RFID, Barcode, Mobility & Voice
    • Robotics
    • Warehouse Management Systems
  • INDUSTRIES
    • Aerospace & Defense
    • Apparel
    • Automotive
    • Chemicals & Energy
    • Consumer Packaged Goods
    • E-Commerce/Omni-Channel
    • Food & Beverage
    • Healthcare
    • High-Tech/Electronics
    • Industrial Manufacturing
    • Pharmaceutical/Biotech
    • Retail
  • REGIONS
    • Asia Pacific
    • Canada
    • China
    • Europe
    • Latin America
    • Middle East/Africa
    • North America
  • THINK TANK
  • WEBINARS
    • On-Demand Webinars
    • Upcoming Webinars
  • PODCASTS
  • VIDEOS
  • WHITEPAPERS
Home » McKesson Sent Pharmacies Tampered Opioids, FDA Warns

McKesson Sent Pharmacies Tampered Opioids, FDA Warns

McKesson Sent Pharmacies Tampered Opioids, FDA Warns
February 13, 2019
Bloomberg

McKesson Corp., one of the largest U.S. drug distributors, sent pharmacies prescription opioids that had been removed from their bottles and replaced with over-the-counter painkillers, the Food and Drug Administration said.

In a warning letter to Chief Executive Officer John Hammergren dated Feb. 7, the FDA said inspections of McKesson’s headquarters in San Francisco and a distribution facility in Oregon last year found the company had failed to respond adequately after being notified by regulators and drugstore customers about the tampered bottles. McKesson also failed to keep proper records of its internal investigation of the matter, the FDA said.

McKesson’s alleged violations show how the legitimate drug-supply chain can be exploited to divert opioids to the illegal market, FDA Commissioner Scott Gottlieb said in an interview Tuesday. “Anyone who is taking custody of controlled substances through the supply chain bears responsibility of ensuring the integrity of the products,” he said.

In September 2016, Rite Aid Corp. notified McKesson that one of its Milford, Michigan, pharmacies had received a bottle of 100 tablets of prescription painkiller oxycodone hydrochloride, which was manufactured by Mallinckrodt Plc. The seal had been broken and the bottle no longer contained the opioid, but rather held 15 tablets of naproxen, the generic name for Aleve.

Rite Aid pharmacies in Warren and Waterford, Michigan, also received tampered bottles of prescription painkillers that no longer contained oxycodone. The FDA letter said McKesson’s investigation into the three incidents suggests that the oxycodone was likely “replaced with other product while the packages were in the possession or control of McKesson.”

The FDA contacted McKesson on July 3 and received responses from the company on July 25, Sept. 25 and Nov. 4. McKesson’s responses demonstrated “a lack of understanding” of the issue, according to the warning letter.

“McKesson takes this situation very seriously,” spokeswoman Kristin Chasen said in an email. “We have been in communication with the FDA over the past several months to respond to their questions and we are in the process of providing additional procedural detail and documentation, including enhancements recently made in response to the FDA’s initial feedback. We are committed to the security of the supply chain and are taking steps to help ensure we comply fully with FDA’s track-and-trace laws for all pharmaceutical products.”

McKesson shares rose 2.6 percent to $133.84 at 2:06 p.m. in New York. The stock has fallen 11 percent in the past 12 months.

Given the severity of the U.S. opioid crisis, Gottlieb said the FDA will focus new efforts on securing potential vulnerabilities in the supply chain. The agency is also developing new guidance on opioids, outlining the risks created by illicit use as well as the safety and effectiveness of new drugs. The report will be published later this year.

“This is a new area of focus for us,” said Gottlieb, noting that legally sold opioids are often subject to theft. “This is a part of a broader vision for trying to make sure we’re providing appropriate vigilance over the legitimate supply chain.”

RELATED CONTENT

RELATED VIDEOS

Regulation & Compliance Supply Chain Security & Risk Mgmt Healthcare Pharmaceutical/Biotech
KEYWORDS healthcare Pharmaceutical/Biotech Regulation & Compliance SC Security & Risk Mgmt
  • Related Articles

    Feds: McKesson Agrees To Pay $150M In Pill Shipment Case

    Independent Pharmacies Are ‘Begging’ for Vaccines

Bloomberg

If Tesla Isn’t Good Enough for an ESG Index, Then Who Is?

More from this author

Wake up to live
“Supply Chains in Crisis”
updates and the latest Supply Chain News!

Subscribe to our Daily Newsletter

Timely, incisive articles delivered directly to your inbox.

Popular Stories

  • Medical drone

    Amazon May Be Proof That Delivery Drones Aren’t Practical

    Last Mile Delivery
  • Warehouse worker

    Why Higher Wages Alone Won’t Solve the Supply Chain Labor Shortage

    Warehousing
  • Adidas

    From Sneakers to Teslas, China Lockdowns Upend Global Supply Chains

    Coronavirus
  • SEC building seal

    Get Ready for the Next Phase of ESG: Mandatory Corporate Due Diligence

    Regulation & Compliance
  • ESG Guide

    Confronting the ESG Imperative in Supply Chains

Digital Edition

Scb may 2022 sm

2022 Supply Chain ESG Guide

VIEW THE LATEST ISSUE

Case Studies

  • 3PL Doubles Productivity With Robots to Fulfill Medical Supply Orders

  • E-Commerce Company Cuts Order Fulfillment Time by 40%

  • Fashion Retailer Halves Fulfillment Time With Omichannel Automation

  • Distributor Scales Business by Integrating Warehouse Automaton Software

  • Fast-Growing Fashion Brand Scales E-Commerce Fulfillment With Whiplash

Visit Our Sponsors

Yang Ming Alithya Barcoding
Blue Yonder BNSF Logistics Generix
GEP GIB USA GreyOrange
Here Honeywell Intelligrated Inmar
Keelvar Kinaxis Korber
Liberty SBF Locus Robotics Lucas Systems
Nvidia Old Dominion Parsyl
Redwood Logistics Saddle Creek Logistics Schneider Dedicated
Setlog Holding AG Ship4WD Shipwell
Tecsys TGW Systems Thomson Reuters
Tive Trailer Bridge Vecna Robotics
Whiplash    
  • More From SCB
    • Featured Content
    • Video Library
    • Think Tank Blog
    • SupplyChainBrain Podcast
    • Whitepapers
    • On-Demand Webinars
    • Upcoming Webinars
  • Digital Offerings
    • Digital Issue
    • Subscribe
    • Manage Your Subscription
    • Newsletters
  • Resources
    • Events Calendar
    • SCB's Great Supply Chain Partners
    • Supplier Directory
    • Case Study Showcase
    • Supply Chain Innovation Awards
    • 100 Great Partners Form
  • SCB Corporate
    • Advertise on SCB.COM
    • About Us
    • Privacy Policy
    • Contact Us
    • Data Sharing Opt-Out

All content copyright ©2022 Keller International Publishing Corp All rights reserved. No reproduction, transmission or display is permitted without the written permissions of Keller International Publishing Corp

Design, CMS, Hosting & Web Development :: ePublishing